Tag: Aurobindo Pharma
CuraTeQ Biologics completes Phase 1 clinical study of BP11 product, a...
The PK/PD trial was conducted in 165 healthy volunteers in Australia and New Zealand
Aurobindo Pharma to invest Rs 300 crore on mammalian cell culture...
The Board also decided that Auro Vaccines will explore the possibilities of offering contract manufacturing to global vaccine developers
Aurobindo Pharma acquires Sandoz’s dermatology, oral solid business in US for...
Agreement comprises the Sandoz US generic oral solids and Sandoz US dermatology businesses with approximately 300 products and H1 2018 sales of USD 0.6 billion. Transaction supports the Sandoz strategy of focusing on complex generics, value-added medicines and biosimilars...……..
Aurobindo Pharma to acquire Apotex’s eastern Europe businesses in a €74...
Acquisition will extend and diversify Aurobindo’s European product portfolio by adding over 200 generics and more than 80 over-the-counter (OTC) products that had total sales of EUR 133 million in the year ending March 2018...…………..
BioVoice eMag March 2017 Issue-10 Volume-1
BioVoice eMag March 2017 Issue-10 Volume-1:
This edition of BioVoice in its detailed cover story highlights the gains and pains of the budget 2017. The...
Aurobindo eyes huge vaccine potential, set to enter market by 2018
In its recent annual report, the Aurobindo Pharma has revealed that it already has set up a huge manufacturing facility with 50 million dosage....